[1]. The Role of Arterial Stiffness as Assessed by the Cardio-Ankle Vascular Index in Patients with Chronic Obstructive Pulmonary Disease.
Respiratory medicine [頁]108078 （2025年） [査読] 有
[2]. Factors Associated with Uncontrolled Severe Asthma in the Biologic Era.
Respiratory medicine [頁]107881 （2024年） [査読] 有
[DOI] [3]. Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic Therapy
CLINICAL LUNG CANCER [巻]27 [号]3 [頁]115 -126 （2026年） [査読] 有
[DOI] [4]. Geriatric nutritional risk index in antifibrotic therapy can predict tolerability and mortality risk.
Scientific reports （2026年） [査読] 有
[5]. Epidemiology of interstitial lung diseases in Japan: A nationwide database analysis.
Respiratory investigation [巻]64 [号]2 [頁]101367 （2026年） [査読] 有
[DOI] [6]. Cold inducible RNA binding protein promotes fibroblast activation and its inhibition represents a potential therapeutic target in pulmonary fibrosis
SCIENTIFIC REPORTS [巻]16 [号]1 （2026年） [査読] 有
[DOI] [7]. Clinical Characteristics and Prevalence of Apical Scarring at Chest CT in a Healthy Population.
Radiology. Cardiothoracic imaging [巻]8 [号]1 [頁]e250190 （2026年） [査読] 有
[DOI] [8]. Using biomarkers and independent predictors of therapy response to optimize treatment of uncontrolled severe asthma in the biologic era
Frontiers in Allergy frontiers [巻]6 [頁]1719820 （2026年） [査読] 有
[9]. 難病治験ウェブの開発と公開―難病の治験情報を患者さんへわかりやすく提供ー
医薬品医療機器レギュラトリーサイエンス誌 [巻]57 [号]1 [頁]34 -38 （2026年） [査読] 有
[10]. Antifibrotic therapy in familial idiopathic pulmonary fibrosis: a comparative cohort study
SCIENTIFIC REPORTS [巻]15 [号]1 （2025年） [査読] 有
[DOI] [11]. Risk stratification of acute exacerbations by autoantibodies in patients with idiopathic interstitial pneumonia
SCIENTIFIC REPORTS [巻]15 [号]1 （2025年） [査読] 有
[DOI] [12]. Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials.
BMC cancer [巻]25 [号]1 [頁]1494 （2025年） [査読] 有
[DOI] [13]. Effectiveness of Statins for Oxaliplatin-Induced Peripheral Neuropathy: A Multicenter Retrospective Observational Study
CTS-CLINICAL AND TRANSLATIONAL SCIENCE [巻]18 [号]10 （2025年） [査読] 有
[DOI] [14]. Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies.
JTO clinical and research reports [巻]6 [号]8 [頁]100847 （2025年） [査読] 有
[DOI] [15]. PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease.
International journal of molecular sciences [巻]26 [号]15 （2025年） [査読] 有
[16]. Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumonia.
Scientific reports [巻]15 [号]1 [頁]26295 （2025年） [査読] 有
[DOI] [17]. Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trial.
Respiratory medicine and research [巻]88 [頁]101191 （2025年） [査読] 有
[18]. Incidence and clinical significance of acute exacerbation of interstitial lung disease in patients with primary Sjögren's syndrome.
Respiratory investigation [巻]63 [号]5 [頁]838 -843 （2025年） [査読] 有
[DOI] [19]. Alveolar Sarcoidosis Mimicking Idiopathic Interstitial Pneumonia Without Mediastinal Lymphadenopathy.
Respirology case reports [巻]13 [号]7 [頁]e70278 （2025年） [査読] 有
[DOI] [20]. Severe drug-induced interstitial lung disease after photoimmunotherapy with cetuximab-sarotalocan sodium in a patient with oropharyngeal cancer: A case report.
Respiratory medicine case reports [巻]57 [頁]102260 （2025年） [査読] 有
[DOI] [21]. Depression and its association with mortality in idiopathic pulmonary fibrosis: A real-world data analysis.
Respiratory medicine [頁]108185 （2025年） [査読] 有
[DOI] [22]. Prognostic value of computed tomography assessment of normal lung volume in upper lobe in idiopathic pleuroparenchymal fibroelastosis
ERJ OPEN RESEARCH [巻]11 [号]3 （2025年） [査読] 有
[DOI] [23]. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study.
Emerging microbes & infections [巻]12 [号]1 [頁]2155250 （2023年） [査読] 有
[DOI] [24]. COPDにおける気道系の定量的CT解析
科学評論社 [巻]44 [号]5 [頁]534 -540 （2023年） [査読] 有
[機関リポジトリ][25]. Predictors of poor clinical outcomes including in-hospital death and low ability to perform activities of daily living at discharge in hospitalized patients with chronic obstructive pulmonary disease exacerbation
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE [巻]17 [頁]17534666231172924 （2023年） [査読] 有
[DOI] [26]. A predictive model for acute exacerbation of idiopathic interstitial pneumonias.
European respiratory journal （2023年） [査読] 有
[DOI] [機関リポジトリ][27]. Predictors of Poor Clinical Outcomes Including In-Hospital Death and Low Ability to Perform Activities of Daily Living at Discharge in Hospitalized Patients with Chronic Obstructive Pulmonary Disease Exacerbation.
Ther Adv Respir Dis （2023年） [査読] 有
[28]. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases.
BMC pulmonary medicine [巻]22 [号]1 [頁]387 （2022年） [査読] 有
[DOI] [29]. Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice.
International journal of molecular sciences [巻]23 [号]16 （2022年） [査読] 有
[DOI] [30]. Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer.
Journal of cancer research and clinical oncology （2022年） [査読] 有
[DOI] [31]. Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
Therapeutic advances in chronic disease [巻]13 [頁]20406223221108395 （2022年） [査読] 有
[DOI] [32]. Frequency, proportion of PF-ILD, and prognosyic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases.
BMC Pulm Med. （2022年） [査読] 有
[33]. Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy.
BMC pulmonary medicine [巻]21 [号]1 [頁]409 （2021年） [査読] 有
[DOI] [34]. Response.
Chest [巻]160 [号]6 [頁]e683 -e685 （2021年） [査読] 有
[DOI] [35]. Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias.
Respiratory research [巻]22 [号]1 [頁]290 （2021年） [査読] 有
[DOI] [36]. MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
JTO clinical and research reports [巻]2 [号]11 [頁]100239 （2021年） [査読] 有
[DOI] [37]. Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis.
Respiratory investigation [巻]59 [号]6 [頁]827 -836 （2021年） [査読] 有
[DOI] [38]. Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas.
Scientific reports [巻]11 [号]1 [頁]14999 （2021年）
[DOI] [39]. Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung.
Allergology international : official journal of the Japanese Society of Allergology [巻]70 [号]3 [頁]351 -359 （2021年）
[DOI] [40]. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
Chest [巻]159 [号]6 [頁]2334 -2345 （2021年）
[DOI] [41]. Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia.
Respiratory research [巻]22 [号]1 [頁]115 （2021年）
[DOI] [42]. Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray.
Scientific reports [巻]11 [号]1 [頁]7669 （2021年）
[DOI] [43]. Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes.
Journal of clinical medicine [巻]10 [号]7 （2021年）
[DOI] [44]. Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
Respirology (Carlton, Vic.) [巻]26 [号]4 [頁]370 -377 （2021年） [査読] 有
[DOI] [機関リポジトリ][45]. Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival.
BMC pulmonary medicine [巻]21 [号]1 [頁]63 （2021年）
[DOI] [46]. Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
Investigational new drugs [巻]39 [号]1 [頁]210 -216 （2021年）
[DOI] [47]. Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease.
Scientific reports [巻]11 [号]1 [頁]1682 （2021年）
[DOI] [48]. Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk Factors.
Respiration; international review of thoracic diseases [巻]100 [号]1 [頁]19 -26 （2021年）
[DOI] [49]. Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide.
Cancer treatment and research communications [巻]29 [頁]100493 （2021年）
[DOI] [50]. Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View.
Journal of pain and symptom management [巻]60 [号]5 [頁]933 -940 （2020年）
[DOI] [51]. Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium.
Respiratory research [巻]21 [号]1 [頁]282 （2020年）
[DOI] [52]. Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium.
Microbiology and immunology [巻]64 [号]10 [頁]666 -678 （2020年）
[DOI] [53]. Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung Cancer.
JAMA network open [巻]3 [号]9 [頁]e2011818 （2020年）
[DOI] [54]. Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [巻]15 [号]8 [頁]1317 -1327 （2020年）
[DOI] [55]. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.
Respirology (Carlton, Vic.) [巻]25 [号]7 [頁]743 -749 （2020年）
[DOI] [56]. Comparison of Chest Compression Quality Using Wing Boards versus Walking Next to a Moving Stretcher: A Randomized Crossover Simulation Study.
Journal of clinical medicine [巻]9 [号]5 （2020年）
[DOI] [57]. Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) [巻]143 [頁]47 -54 （2020年）
[DOI] [58]. Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.
Scientific reports [巻]10 [号]1 [頁]3324 （2020年）
[DOI] [59]. Pulse oximetric saturation to fraction of inspired oxygen (SpO/FIO) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620906327 （2020年）
[DOI] [60]. Pneumothorax in connective tissue disease-associated interstitial lung disease.
PloS one [巻]15 [号]7 [頁]e0235624 （2020年）
[DOI] [61]. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620935774 （2020年）
[DOI] [62]. Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620953783 （2020年）
[DOI] [63]. Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.
Scientific reports [巻]9 [号]1 [頁]18750 （2019年）
[DOI] [64]. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.
Rheumatology (Oxford, England) [巻]58 [号]12 [頁]2143 -2152 （2019年）
[DOI] [65]. Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer.
Internal medicine (Tokyo, Japan) [巻]58 [号]22 [頁]3267 -3271 （2019年）
[DOI] [66]. Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung Cancer.
Internal medicine (Tokyo, Japan) [巻]58 [号]22 [頁]3299 -3304 （2019年）
[DOI] [67]. Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Respiratory investigation [巻]57 [号]6 [頁]552 -560 （2019年）
[DOI] [68]. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
Respiratory medicine [巻]159 [頁]105811 （2019年）
[DOI] [69]. Minute Pulmonary Meningothelial-like Nodules Showing Multiple Ring-shaped Opacities.
Internal medicine (Tokyo, Japan) [巻]58 [号]21 [頁]3149 -3152 （2019年）
[DOI] [70]. Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung disease.
The Journal of infection [巻]79 [号]4 [頁]341 -348 （2019年）
[DOI] [71]. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
The Journal of rheumatology [巻]46 [号]8 [頁]935 -942 （2019年）
[DOI] [72]. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Respirology (Carlton, Vic.) [巻]24 [号]8 [頁]792 -798 （2019年）
[DOI] [73]. Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Scientific reports [巻]9 [号]1 [頁]10484 （2019年）
[DOI] [74]. Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.
Cancer chemotherapy and pharmacology [巻]84 [号]1 [頁]147 -153 （2019年）
[DOI] [75]. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Investigational new drugs [巻]37 [号]3 [頁]531 -537 （2019年）
[DOI] [76]. Physiological and morphological differences of airways between COPD and asthma-COPD overlap.
Scientific reports [巻]9 [号]1 [頁]7818 （2019年）
[DOI] [77]. Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion.
The European respiratory journal [巻]53 [号]5 （2019年）
[DOI] [78]. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
The Journal of rheumatology [巻]46 [号]5 [頁]509 -517 （2019年）
[DOI] [79]. Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities.
American journal of respiratory and critical care medicine [巻]199 [号]8 [頁]1031 -1033 （2019年）
[DOI] [80]. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
Chronic respiratory disease [巻]16 [頁]1479972318809476 （2019年）
[DOI] [81]. Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.
Respiratory medicine [巻]154 [頁]102 -108 （2019年）
[DOI] [82]. Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.
International journal of chronic obstructive pulmonary disease [巻]14 [頁]1333 -1342 （2019年）
[DOI] [83]. Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial.
Journal of asthma and allergy [巻]12 [頁]253 -261 （2019年）
[DOI] [84]. Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.
Respiratory medicine [巻]146 [頁]76 -80 （2019年）
[DOI] [85]. Differences in airway structural changes assessed by 3-dimensional computed tomography in asthma and asthma-chronic obstructive pulmonary disease overlap.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [巻]121 [号]6 [頁]704 -710.e1 （2018年）
[DOI] [86]. An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases.
Internal medicine (Tokyo, Japan) [巻]57 [号]23 [頁]3423 -3427 （2018年）
[DOI] [87]. IL-17A Attenuates IFN-λ Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium.
Journal of immunology (Baltimore, Md. : 1950) [巻]201 [号]8 [頁]2392 -2402 （2018年）
[DOI] [88]. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis.
Scientific reports [巻]8 [号]1 [頁]14074 （2018年）
[DOI] [89]. Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis.
Medical oncology (Northwood, London, England) [巻]35 [号]11 [頁]139 （2018年）
[DOI] [90]. Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis.
Scientific reports [巻]8 [号]1 [頁]13129 （2018年）
[DOI] [91]. Neurogenic Pulmonary Edema without Norepinephrine Elevation.
Internal medicine (Tokyo, Japan) [巻]57 [号]14 [頁]2097 -2098 （2018年）
[DOI] [92]. Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study.
Medical oncology (Northwood, London, England) [巻]35 [号]7 [頁]108 （2018年）
[DOI] [93]. Neutrophil gelatinase-associated lipocalin in patients with sarcoidosis.
Respiratory medicine [巻]138S [頁]S20 -S23 （2018年）
[DOI] [94]. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia.
Respiratory medicine [巻]137 [頁]167 -175 （2018年）
[DOI] [95]. Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease.
Clinical medicine insights. Circulatory, respiratory and pulmonary medicine [巻]12 [頁]1179548418771702 （2018年）
[DOI] [96]. Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.
PloS one [巻]13 [号]6 [頁]e0199659 （2018年）
[DOI] [97]. Direct pulmonary infiltrates as an initial manifestation of chronic lymphocytic leukemia.
Respiratory medicine case reports [巻]25 [頁]282 -285 （2018年）
[DOI] [98]. Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study.
Respiratory medicine [巻]133 [頁]1 -5 （2017年）
[DOI] [99]. Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury.
American journal of physiology. Lung cellular and molecular physiology [巻]311 [号]1 [頁]L74 -86 （2016年）
[DOI] [100]. Idiopathic Nonsurgical Pneumoperitoneum Accompanied by a Pneumomediastinum.
Internal medicine (Tokyo, Japan) [巻]55 [号]15 [頁]2125 -6 （2016年）
[DOI] [101]. A severe case of acute exogenous lipoid pneumonia treated with systemic corticosteroid.
Respiratory medicine case reports [巻]17 [頁]64 -7 （2016年）
[DOI] [102]. Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease.
Pulmonary pharmacology & therapeutics [巻]30 [頁]11 -5 （2015年）
[DOI] [103]. A case of spontaneous regression of pulmonary mucosa-associated lymphoid tissue (MALT) type lymphoma with Sjögren's syndrome treated with methotrexate for rheumatoid arthritis.
Respiratory medicine case reports [巻]15 [頁]4 -6 （2015年）
[DOI] [104]. Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease.
International journal of chronic obstructive pulmonary disease [巻]10 [頁]1139 -46 （2015年）
[DOI] [105]. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
Pulmonary pharmacology & therapeutics [巻]27 [号]1 [頁]52 -6 （2014年）
[DOI] [106]. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Thrombosis research [巻]132 [号]1 [頁]100 -5 （2013年）
[DOI] [107]. Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease.
Pulmonary pharmacology & therapeutics [巻]26 [号]3 [頁]336 -41 （2013年）
[DOI] [108]. Alveolar nitric oxide concentration reflects peripheral airway obstruction in stable asthma.
Respirology (Carlton, Vic.) [巻]18 [号]3 [頁]522 -7 （2013年）
[DOI] [109]. Effect of switching from salmeterol/fluticasone to formoterol/ budesonide combinations in patients with uncontrolled asthma.
Allergology international : official journal of the Japanese Society of Allergology [巻]61 [号]2 [頁]323 -9 （2012年）
[DOI] [110]. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation.
Respiratory medicine [巻]106 [号]4 [頁]508 -14 （2012年）
[DOI] [111]. Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells.
Blood [巻]118 [号]11 [頁]3182 -5 （2011年）
[DOI] [112]. [A case of pulmonary tumor thrombotic microangiopathy induced by early gastric cancer].
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society [巻]49 [号]2 [頁]122 -7 （2011年）
[113]. [Three cases of hypersensitivity pneumonitis in citrus farmers].
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society [巻]48 [号]2 [頁]172 -7 （2010年）